<?xml version='1.0' encoding='UTF-8'?>
<PolymerNanocomposite><PDB_ID>3CTQ</PDB_ID><DATA_SOURCE><Citation><CitationType>research article</CitationType><Publication>Bioorganic &amp; Medicinal Chemistry Letters</Publication><Title>Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase</Title><Author>Cogan, D.A.</Author><Author>Aungst, R.</Author><Author>Breinlinger, E.C.</Author><Author>Fadra, T.</Author><Author>Goldberg, D.R.</Author><Author>Hao, M.H.</Author><Author>Kroe, R.</Author><Author>Moss, N.</Author><Author>Pargellis, C.</Author><Author>Qian, K.C.</Author><Author>Swinamer, A.D.</Author><Publisher>Elsevier</Publisher><PublicationYear>2008</PublicationYear><DOI>10.1016/j.bmcl.2008.04.043</DOI><Volume>18</Volume><Issue>11</Issue></Citation></DATA_SOURCE><MATERIALS><Matrix><MatrixComponent><ChemicalName>Mitogen-activated protein kinase 14</ChemicalName><MacroMoleculeClass>TRANSFERASE</MacroMoleculeClass><MacroMoleculeType>Protein</MacroMoleculeType><ManufacturerOrSourceName>Homo sapiens</ManufacturerOrSourceName><MolecularWeight><value>40391.28</value></MolecularWeight></MatrixComponent></Matrix></MATERIALS><CHARACTERIZATION><XRay_Diffraction_and_Scattering><Equipment>RIGAKU RU300</Equipment><Description>Resolution: 1.95</Description></XRay_Diffraction_and_Scattering></CHARACTERIZATION><PROPERTIES><Biological><Sequence>RPTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPP</Sequence><SpaceGroup>P 21 21 21</SpaceGroup></Biological></PROPERTIES></PolymerNanocomposite>